Further monographs for use of immunosuppressants in Immune-related adverse events (irAEs)
Earlier this year the BOPA Immunotherapy Group wrote, and published, four monographs to help health care professionals care for patients with immune-related adverse events.
As a group we are pleased to publish another three, that will be available on the resource section of the BOPA Immunotherapy Group section of the BOPA website. In addition, they are available on the Clinical Guidelines Section of the Immuno-Oncology Clinical Network website. Drugs now available are
- Abatacept
- Infliximab
- Methotrexate
- Mycophenolate
- Tacrolimus
- Tocilizumab
- Vedolizumab
The monographs are also available via the useful website pages or directly from this link.
A HUGE thank you to the members of the group for their hard work in producing these. Any feedback anyone has will be much appreciated. Watch this space for more to come later in the year!
